Author:
Momm F.,Meßmer M.-B.,Kirste S.,Becker G.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Allal AS, Dulguerov P, Bieri S et al (2000) Assessment of quality of life in patients treated with accelerated radiotherapy for laryngeal and hypopharyngeal carcinomas. Head Neck 22:288–293
2. Aulbert E, Radbruch L, Grond S, Zech D (1997) Prinzipien der Symptombehandlung. In: Aulbert E, Zech D (Hrsg) Lehrbuch der Palliativmedizin. Schattauer, Stuttgart New York, S 167–173
3. Brizel DM, Wasserman TH, Henke M et al (2000) Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339–3345
4. Dirix P, Nuyts S, Vander Poorten V et al (2008) The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer. Support Care Cancer 16:171–179
5. Eisbruch A (2007) Reducing xerostomia by IMRT: what may, and may not, be achieved. J Clin Oncol 25:4863–4864